Lion Point Capital, LP KINIKSA PHARMACEUTICALS LTD Transaction History
Lion Point Capital, LP
- $8.91 Million
- Q2 2025
Number of Shares
45,900
Previous 45,900
-0.0%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%